Search

Your search keyword '"Walker A"' showing total 2,913 results

Search Constraints

Start Over You searched for: Author "Walker A" Remove constraint Author: "Walker A" Journal blood Remove constraint Journal: blood
2,913 results on '"Walker A"'

Search Results

1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

2. PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

5. Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma

7. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis

8. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD

10. LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses

11. Somatic Hypermutation in Enhancer Regions Shapes Non-Coding Myeloma Genome, Generating DNA Breaks and Driving Etiology through Mutation and Structural Variation

12. Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

14. DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

15. Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

16. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

17. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

18. Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma

19. CK2β regulates thrombopoiesis and Ca2+-triggered platelet activation in arterial thrombosis

20. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations

21. Sex-Associated Differences in Frequencies and Outcome Prognostication of Recurrent Molecular Features in Adults with Acute Myeloid Leukemia (AML) (AMLCG, CALGB [Alliance])

22. Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial

24. The multifaceted role of platelets in mediating brain function

25. Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

26. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

27. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

30. Secondary AML Mutations Confer Poor Prognosis in Patients with ELN Favorable Risk NPM1-Mutated AML

31. Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

32. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

33. Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

35. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

36. A Retrospective Cohort Study of Donor Cell Leukemia

37. Secondary AML Mutations Confer Poor Prognosis in Patients with ELN Favorable Risk NPM1-Mutated AML

38. Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma

39. Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

40. Dysregulation of PRMT5 in Chronic Lymphocytic Leukemia Supports Transformation to Diffuse Large B-Cell Lymphoma

44. High Ex Vivo Response Rates to CD38/CD28xCD3 Trispecific T Cell Engager in Patients Relapsed after Anti-CD38 and Anti-BCMA Targeted Immunotherapies

45. The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma

47. Genome-Wide CRISPR/Cas9 Knockout Screen Reveals Novel Gilteritinib Combinations Targeting Oxidative Phosphorylation and De-Novo Purine Biosynthesis Pathways for FLT3-ITD+ Acute Myeloid Leukemia

50. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss

Catalog

Books, media, physical & digital resources